High-dose radioimmunotherapy in refractory B-cell non-Hodgikin's lymphoma with I-131-labeled chimeric anti CD-20 C2B8 (I-131 rituximab): pilot trial

Kim, Sung-Eun (Department of Nuclear Medicine, Korea Institute or Radiological and Medical Science) ;
Park, Yeon-Hee (Department of Internal Medicine, Korea Institute or Radiological and Medical Science) ;
Cheon, Gi-Jeong (Department of Nuclear Medicine, Korea Institute or Radiological and Medical Science) ;
Ryoo, Baek-Yeol (Department of Internal Medicine, Korea Institute or Radiological and Medical Science) ;
Lee, Seung-Sook (Division of Hematology and Oncology, Korea Institute or Radiological and Medical Science) ;
Choi, Chang-Woon (Department of Nuclear Medicine, Korea Institute or Radiological and Medical Science) ;
Lim, Sang-Moo (Department of Nuclear Medicine, Korea Institute or Radiological and Medical Science)